Inventiva S.A.(IVA)Earnings, Financials & Key Ratios
IVA•NASDAQ
Price updated Jun 11, 2026
AboutInventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of MPS VI subtype disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company has strategic collaboration with AbbVie for the treatment of autoimmune diseases; and Boehringer Ingelheim International GmbH for developing new treatments for idiopathic pulmonary fibrosis. Inventiva S.A. was founded in 2011 and is based in Daix, France.Show more
- Revenue$9M-47.4%
- EBITDA-$92M+7.7%
- Net Income-$184M-66.8%
- EPS (Diluted)-3.54-45.7%
- Gross Margin100%-0.1%
- EBITDA Margin-1004.13%-75.3%
- Operating Margin-1060.64%-80.5%
- Net Margin-2002.74%-217.0%
- Interest Coverage-8.01+59.6%
IVA Key Insights
Inventiva S.A. (IVA) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
No significant strengths identified
✗Weaknesses
- ✗Weak Piotroski F-Score: 2/9
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 16 (bottom 16%)
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Shares diluted 14.6% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when IVA posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
IVA Price & Volume
Inventiva S.A. (IVA) stock price & volume — 10-year historical chart
Loading chart...
IVA Growth Metrics
Inventiva S.A. (IVA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years10.85%
5 Years5.62%
3 Years29.92%
TTM15.39%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-205.24%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-91.19%
Return on Capital
10 Years-164.67%
5 Years-289.23%
3 Years-454.76%
Last Year-1106.16%
IVA Recent Earnings
Inventiva S.A. (IVA) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 5/12 qtrs (42%)●Beat Revenue 5/12 qtrs (45%)
Q2 2026Latest
Mar 30, 2026EPS
$1.07
Est $0.23
-365.2%
Revenue
$2M
Est $5M
-55.3%
Q4 2025
Sep 25, 2025EPS
$1.89
Est $0.41
-361.7%
Revenue
$5M
Est $9M
-39.8%
Q2 2025
May 23, 2025EPS
$2.69
Est $0.47
-472.9%
Revenue
$7M
Est $6M
+4.6%
Q4 2024
Sep 25, 2024EPS
$1.01
Est $0.56
-81.1%
Revenue
$3M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Mar 30, 2026 | $1.07vs $0.23-365.2% | $2Mvs $5M-55.3% |
| Q4 2025 | Sep 25, 2025 | $1.89vs $0.41-361.7% | $5Mvs $9M-39.8% |
| Q2 2025 | May 23, 2025 | $2.69vs $0.47-472.9% | $7Mvs $6M+4.6% |
| Q4 2024 | Sep 25, 2024 | $1.01vs $0.56-81.1% | $3M |
Based on last 12 quarters of dataView full earnings history →
IVA Peer Comparison
Inventiva S.A. (IVA) competitors in Metabolic and Obesity Therapies — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 MDGL | 10.93B | 474.28 | -36.91 | 432.05% | -27.32% | -50.15% | 0.59 | |
 AKBA | 241.27M | 0.90 | -43.24 | 47.46% | -8.83% | -62.72% | 6.63 | |
 HALO | 8.39B | 70.73 | 27.63 | 37.55% | 23.13% | 126.27% | 43.89 | |
 CLDX | 1.99B | 29.96 | -7.68 | -78.63% | -345.96% | -50.72% | 0.00 | |
 GNFT | 447.53M | 8.95 | 256.88 | 134.56% | -14.12% | -22.98% | 0.90 | |
 VKTX | 3.32B | 28.61 | -8.97 | -71.31% | 0.00 | |||
 ARWR | 10.48B | 74.41 | -6099.18 | 232.58% | -48.38% | -55.09% | 0.73 | |
 ALDX | 103.15M | 1.71 | -3.05 | -0% | 0.35 |
Compare IVA vs Peers
Inventiva S.A. (IVA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
IVA Income Statement
Inventiva S.A. (IVA) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 9.45M | 6.52M | 3.2M | 7M | 372K | 4.19M | 12.18M | 17.48M | 9.2M | 30.19M |
Revenue Growth % | 93.77% | -30.96% | -50.97% | 118.89% | -94.68% | 1027.42% | 190.39% | 43.5% | -47.37% | 15.39% |
Cost of Goods Sold | 1.49M | 1.24M | 967K | 0 | 846K | 0 | 995K | -23K | 0 | 2.26M |
COGS % of Revenue | 15.73% | 18.95% | 30.25% | - | 227.42% | - | 8.17% | -0.13% | - | - |
Gross Profit | 7.96M▲ 0% | 5.28M▼ 33.6% | 2.23M▼ 57.8% | 7M▲ 213.8% | 4.42M▼ 36.9% | 4.19M▼ 5.0% | 17.06M▲ 306.7% | 17.5M▲ 2.6% | 9.2M▼ 47.4% | 27.93M▲ 0% |
Gross Margin % | 84.27% | 81.05% | 69.75% | 100% | 1187.37% | 100% | 140.05% | 100.13% | 100% | 92.51% |
Gross Profit Growth % | 129.4% | -33.6% | -57.8% | 213.81% | -36.88% | -5.05% | 306.7% | 2.6% | -47.44% | - |
Operating Expenses | 21.49M | 26.99M | 36.41M | 36.21M | 34.13M | 56.31M | 74.17M | 120.19M | 106.76M | 230M |
OpEx % of Revenue | 227.56% | 413.86% | 1139.04% | 517.48% | 9176.08% | 1342.61% | 608.97% | 687.68% | 1160.64% | - |
Selling, General & Admin | 3.3M | 4.12M | 4.52M | 4.51M | 9.06M | 11.52M | 15.49M | 15.61M | 17.1M | 41.07M |
SG&A % of Revenue | 34.9% | 63.25% | 141.41% | 64.5% | 2436.02% | 274.68% | 127.23% | 89.3% | 185.9% | - |
Research & Development | 22.14M | 26.73M | 31.64M | 33.79M | 23.72M | 48.45M | 60.47M | 110.01M | 90.88M | 190.14M |
R&D % of Revenue | 234.44% | 409.96% | 989.58% | 482.87% | 6375.54% | 1155.27% | 496.5% | 629.47% | 988.04% | - |
Other Operating Expenses | 0 | 0 | 257K | -2.09M | 1.36M | -3.66M | -1.8M | -5.43M | -1.22M | -1.21M |
Operating Income | -13.02M▲ 0% | -20.92M▼ 60.7% | -33.25M▼ 59.0% | -30.31M▲ 8.8% | -29.72M▲ 2.0% | -52.11M▼ 75.4% | -57.11M▼ 9.6% | -102.71M▼ 79.8% | -97.56M▲ 5.0% | -202.07M▲ 0% |
Operating Margin % | -137.83% | -320.76% | -1040.13% | -433.15% | -7988.71% | -1242.58% | -468.92% | -587.68% | -1060.64% | -669.25% |
Operating Income Growth % | 16.06% | -60.66% | -58.98% | 8.84% | 1.96% | -75.36% | -9.59% | -79.84% | 5.02% | - |
EBITDA | -11.53M | -19.68M | -32.3M | -28.86M | -28.87M | -51.26M | -56.24M | -100.11M | -92.36M | -195.44M |
EBITDA Margin % | -122.1% | -301.8% | -1010.45% | -412.35% | -7760.48% | -1222.13% | -461.78% | -572.81% | -1004.13% | -647.3% |
EBITDA Growth % | 18.83% | -70.64% | -64.15% | 10.67% | -0.05% | -77.55% | -9.72% | -78% | 7.74% | -36.39% |
D&A (Non-Cash Add-back) | 1.49M | 1.24M | 949K | 1.46M | 849K | 858K | 870K | 2.6M | 5.2M | 6.63M |
EBIT | -12.06M | -22.89M | -33.01M | -30.21M | -32.62M | -53.62M | -57.16M | -104.64M | -171.72M | -386.98M |
Net Interest Income | 488.66K | 271K | -101.46K | 138K | 160K | -81K | -317K | -4.23M | -11.07M | -22.4M |
Interest Income | 230.18K | 276.62K | 141.57K | 157K | 226K | 57K | 390K | 945K | 1.14M | 2.77M |
Interest Expense | 7.55K | 5.32K | 243.03K | 3K | 66K | 138K | 707K | 5.18M | 12.18M | 25.14M |
Other Income/Expense | 460.23K | 278K | -111K | 95K | -3.9M | 2.84M | 2.82M | -7.11M | -86.34M | -213.89M |
Pretax Income | -12.56M▲ 0% | -20.64M▼ 64.3% | -33.36M▼ 61.7% | -30.22M▲ 9.4% | -33.62M▼ 11.3% | -49.27M▼ 46.6% | -54.29M▼ 10.2% | -109.82M▼ 102.3% | -183.9M▼ 67.5% | -415.95M▲ 0% |
Pretax Margin % | -132.96% | -316.49% | -1043.57% | -431.79% | -9037.1% | -1174.82% | -445.8% | -628.36% | -1999.36% | -1377.65% |
Income Tax | -5.51M | -3.41M | 253K | 0 | 0 | 364K | -20K | 607K | 313K | -701K |
Effective Tax Rate % | 43.9% | 16.52% | -0.76% | 0% | 0% | -0.74% | 0.04% | -0.55% | -0.17% | 0.17% |
Net Income | -7.05M▲ 0% | -17.23M▼ 144.6% | -33.62M▼ 95.1% | -30.22M▲ 10.1% | -33.62M▼ 11.2% | -49.64M▼ 47.6% | -54.27M▼ 9.3% | -110.43M▼ 103.5% | -184.21M▼ 66.8% | -415.25M▲ 0% |
Net Margin % | -74.59% | -264.22% | -1051.49% | -431.85% | -9037.37% | -1183.5% | -445.64% | -631.84% | -2002.74% | -1375.32% |
Net Income Growth % | 20.15% | -144.56% | -95.11% | 10.1% | -11.24% | -47.64% | -9.34% | -103.46% | -66.82% | -205.24% |
Net Income (Continuing) | -7.05M | -19.08M | -33.62M | -30.22M | -33.62M | -49.63M | -54.27M | -110.43M | -184.21M | -415.25M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -0.45▲ 0% | -1.11▼ 146.7% | -1.64▼ 47.7% | -1.28▲ 22.0% | -0.99▲ 22.7% | -1.27▼ 28.3% | -1.31▼ 3.1% | -2.43▼ 85.5% | -3.54▼ 45.7% | -3.82▲ 0% |
EPS Growth % | 48.86% | -146.67% | -47.75% | 21.95% | 22.66% | -28.28% | -3.15% | -85.5% | -45.68% | -91.19% |
EPS (Basic) | -0.45 | -1.11 | -1.64 | -1.28 | -0.99 | -1.27 | -1.31 | -2.43 | -3.54 | - |
Diluted Shares Outstanding | 15.74M | 15.52M | 20.54M | 23.52M | 33.87M | 39.17M | 41.45M | 45.35M | 51.98M | 108.84M |
Basic Shares Outstanding | 15.68M | 15.52M | 20.54M | 23.52M | 33.87M | 39.17M | 41.45M | 45.35M | 51.98M | 108.84M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
IVA Balance Sheet
Inventiva S.A. (IVA) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 41.25M | 67.22M | 71.63M | 48.88M | 133M | 115.58M | 106.38M | 48.19M | 111.51M | 172.37M |
Cash & Short-Term Investments | 24.87M | 59.05M | 56.69M | 35.84M | 113.02M | 86.55M | 87.78M | 27.34M | 96.56M | 122.08M |
Cash Only | 24.87M | 59.05M | 56.69M | 35.84M | 105.69M | 86.55M | 86.74M | 26.92M | 96.56M | 122.08M |
Short-Term Investments | 0 | 0 | 0 | 0 | 7.34M | 0 | 1.05M | 70K | 0 | 0 |
Accounts Receivable | 4.5M | 6.86M | 13.32M | 643K | 48K | 11.59M | 279K | 15.71M | 12.16M | 22.79M |
Days Sales Outstanding | 173.97 | 383.99 | 1.52K | 33.54 | 47.1 | 1.01K | 8.36 | 328.03 | 482.42 | 155.54 |
Inventory | 471.88K | 473.13K | 410K | 387K | 320K | 392K | 373K | 417K | 0 | 0 |
Days Inventory Outstanding | 115.9 | 139.72 | 154.76 | - | 138.06 | - | 136.83 | -6.62K | - | 32.68 |
Other Current Assets | 13.55M | 0 | 32K | 11.51M | 16.29M | 9.59M | 9.35M | 69K | 349K | 24.58M |
Total Non-Current Assets | 7.61M | 7.15M | 8.18M | 8.08M | 5.92M | 6.41M | 9.62M | 21.37M | 7.46M | 6.14M |
Property, Plant & Equipment | 4.96M | 4.52M | 4.26M | 3.72M | 3.28M | 3.2M | 7.39M | 9.13M | 5M | 3.98M |
Fixed Asset Turnover | 1.91x | 1.44x | 0.75x | 1.88x | 0.11x | 1.31x | 1.65x | 1.91x | 1.84x | 4.63x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 2.07M | 1.81M | 1.54M | 1.23M | 935K | 770K | 568K | 541K | 48K | 85K |
Long-Term Investments | 385.82K | 238.62K | 2.27M | 2.33M | 1.7M | 1.75M | 700K | 1.43M | 1.14M | 4.53M |
Other Non-Current Assets | 0 | 333.33K | 2.37M | 3.13M | 8K | -2K | 968K | 10.05M | 1.05M | 1.05M |
Total Assets | 48.86M▲ 0% | 74.37M▲ 52.2% | 79.81M▲ 7.3% | 56.96M▼ 28.6% | 138.92M▲ 143.9% | 121.98M▼ 12.2% | 116M▼ 4.9% | 69.56M▼ 40.0% | 118.97M▲ 71.0% | 178.52M▲ 0% |
Asset Turnover | 0.19x | 0.09x | 0.04x | 0.12x | 0.00x | 0.03x | 0.10x | 0.25x | 0.08x | 0.30x |
Asset Growth % | -19.34% | 52.2% | 7.32% | -28.63% | 143.89% | -12.19% | -4.9% | -40.04% | 71.03% | 339.45% |
Total Current Liabilities | 8.6M | 8.79M | 15.08M | 13.87M | 13.91M | 22.85M | 30.7M | 50.16M | 120.73M | 58.46M |
Accounts Payable | 4.36M | 5.38M | 8.37M | 7.49M | 6.92M | 14.6M | 19.36M | 37.68M | 32.86M | 34.7M |
Days Payables Outstanding | 1.07K | 1.59K | 3.16K | - | 2.99K | - | 7.1K | -597.95K | - | 5.72K |
Short-Term Debt | 145.75K | 307K | 2.13M | 77K | 16K | 1.24M | 4.57M | 3.01M | 3.35M | 5.53M |
Deferred Revenue (Current) | 1.68M | 592.65K | 548K | 2.11M | 0 | 0 | 6K | 6K | 0 | 9K |
Other Current Liabilities | 1.09M | 977K | 1.89M | 475K | 5.56M | 5.74M | 2.28M | 5.63M | 73.4M | 12.68M |
Current Ratio | 4.80x | 7.64x | 4.75x | 3.53x | 9.56x | 5.06x | 3.47x | 0.96x | 0.92x | 2.95x |
Quick Ratio | 4.74x | 7.59x | 4.72x | 3.50x | 9.54x | 5.04x | 3.45x | 0.95x | 0.92x | 2.95x |
Cash Conversion Cycle | -782.09 | -1.07K | -1.49K | - | -2.8K | - | -6.96K | 591.66K | - | -5.53K |
Total Non-Current Liabilities | 4.54M | 1.56M | 3.13M | 1.7M | 13.8M | 10.27M | 39.83M | 51.43M | 104.88M | 129.41M |
Long-Term Debt | 481.86K | 220K | 74K | 0 | 10.04M | 8.74M | 25.43M | 27.91M | 46.33M | 51.6M |
Capital Lease Obligations | 0 | 0 | 0 | 2K | 0 | 92K | 3.23M | 4.27M | 2.13M | 9.71M |
Deferred Tax Liabilities | 3.01M | -1.9M | 9.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 944.42K | 1.34M | 1.39M | 1.7M | 3.76M | 1.43M | 11.11M | 19.25M | 56.31M | 77.68M |
Total Liabilities | 13.14M | 10.36M | 18.22M | 15.57M | 27.71M | 33.12M | 70.53M | 101.59M | 225.61M | 187.87M |
Total Debt | 627.6K | 482.07K | 2.2M | 114K | 10.06M | 10.12M | 34.51M | 37.49M | 54.33M | 57.13M |
Net Debt | -24.24M | -58.57M | -54.49M | -35.73M | -92.43M | -76.43M | -52.22M | 10.57M | -42.23M | -64.94M |
Debt / Equity | 0.02x | 0.01x | 0.04x | 0.00x | 0.09x | 0.11x | 0.76x | - | - | -6.11x |
Debt / EBITDA | - | - | - | - | - | - | - | - | - | -0.29x |
Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | 0.33x |
Interest Coverage | -1724.82x | -3934.53x | -136.83x | -10104.00x | -450.27x | -377.64x | -80.78x | -19.84x | -8.01x | -15.39x |
Total Equity | 35.72M▲ 0% | 64.01M▲ 79.2% | 61.6M▼ 3.8% | 41.39M▼ 32.8% | 111.21M▲ 168.7% | 88.87M▼ 20.1% | 45.48M▼ 48.8% | -32.03M▼ 170.4% | -106.65M▼ 232.9% | -9.35M▲ 0% |
Equity Growth % | -16.48% | 79.18% | -3.77% | -32.8% | 168.68% | -20.09% | -48.83% | -170.44% | -232.94% | -1246.38% |
Book Value per Share | 2.27 | 4.13 | 3.00 | 1.76 | 3.28 | 2.27 | 1.10 | -0.71 | -2.05 | -0.09 |
Total Shareholders' Equity | 35.72M | 64.01M | 61.6M | 41.39M | 111.21M | 88.87M | 45.48M | -32.03M | -106.65M | -9.35M |
Common Stock | 100.3K | 164.44K | 223K | 268K | 386K | 409K | 421K | 521K | 957K | 1.39M |
Retained Earnings | -7.05M | -17.23M | -33.62M | -30.22M | -33.62M | -49.63M | -54.27M | -110.43M | -184.21M | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -437K |
Accumulated OCI | 42.67M | 36.08M | 17.53M | -14.67M | 4.78M | -26.98M | -74.56M | -123.99M | -172.55M | -387.06M |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
IVA Cash Flow Statement
Inventiva S.A. (IVA) cash flow — operating, investing & free cash flow history
| Metric | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -14.86M | -17M | -34.21M | -28.4M | -30.59M | -47.63M | -44.93M | -81.61M | -85.93M | -176.2M |
Operating CF Margin % | -157.33% | -260.73% | -1069.97% | -405.89% | -8223.12% | -1135.65% | -368.9% | -466.98% | -934.2% | - |
Operating CF Growth % | -6.27% | -14.41% | -101.19% | 16.96% | -7.7% | -55.7% | 5.67% | -81.66% | -5.29% | -116.15% |
Net Income | -7.05M | -17.23M | -33.62M | -30.22M | -33.62M | -49.63M | -54.27M | -110.43M | -184.21M | -415.25M |
Depreciation & Amortization | 1.65M | 1.42M | 2.32M | 1.58M | 1.89M | -1.29M | 1.7M | 2.6M | 5.2M | 8.36M |
Stock-Based Compensation | 3.1M | 683.61K | 833K | 1.41M | 938K | 2.09M | 2.22M | 3.97M | 3.58M | 5.5M |
Deferred Taxes | -9.81M | -7.87M | -4.72M | -4.3M | -7.65M | -3.27M | -5.26M | -4.74M | -4.8M | -1.13M |
Other Non-Cash Items | -80.3K | 3.45M | 5K | 3.89M | 9.83M | 3.5M | 4.98M | 9.68M | 92.63M | 225.71M |
Working Capital Changes | -2.68M | 2.55M | 974K | -769K | -1.97M | 979K | 5.71M | 17.31M | 1.68M | 598K |
Change in Receivables | -2.86M | 1.82M | -3.09M | 1.78M | -459K | -5.32M | 3.84M | -5.84M | 2.81M | -6.21M |
Change in Inventory | 8.56K | -1.25K | 30K | 22K | 68K | -72K | 19K | -44K | 417K | 425K |
Change in Payables | 924.63K | 3.33M | 4.82M | -2.97M | 1.27M | 7.6M | 3.54M | 20M | 0 | 8.44M |
Cash from Investing | 17.2M | 6.17M | -420K | -826K | -8.56M | -1.79M | 8.87M | -7.73M | 8.74M | -16.08M |
Capital Expenditures | -227.94K | -428.03K | -549K | -136K | -292K | -534K | -561K | -540K | -333K | -700K |
CapEx % of Revenue | 2.41% | 6.56% | 17.17% | 1.94% | 78.49% | 12.73% | 4.61% | 3.09% | 3.62% | 2.32% |
Acquisitions | 17.43M | 6.19M | 0 | 3K | 0 | 89K | 41K | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | -10.25K | 631 | 23K | -690K | 0 | 90K | 1K | 131K | 0 | -19K |
Cash from Financing | -70.86K | 45.01M | 32.27M | 8.38M | 111.67M | 25.45M | 37.27M | 29.08M | 145.59M | 281.77M |
Debt Issued (Net) | -70.86K | -146K | -259K | -146K | 9.89M | -28K | 28.44M | -4.1M | 19.92M | 40.69M |
Equity Issued (Net) | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 2M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | 0 | 1K | 1K | -130K | 0 | 0 | 0 | 5.1M | 68.33M | 75.69M |
Net Change in Cash | 2.27M▲ 0% | 34.18M▲ 1404.7% | -2.36M▼ 106.9% | -20.85M▼ 783.9% | 69.85M▲ 435.0% | -19.13M▼ 127.4% | 183K▲ 101.0% | -59.82M▼ 32787.4% | 69.65M▲ 216.4% | 127.9M▲ 0% |
Free Cash Flow | -15.09M▲ 0% | -17.43M▼ 15.5% | -34.76M▼ 99.4% | -28.54M▲ 17.9% | -30.88M▼ 8.2% | -48.16M▼ 56.0% | -45.49M▲ 5.6% | -82.15M▼ 80.6% | -86.26M▼ 5.0% | -176.9M▲ 0% |
FCF Margin % | -159.74% | -267.3% | -1087.14% | -407.83% | -8301.61% | -1148.38% | -373.5% | -470.07% | -937.82% | -585.9% |
FCF Growth % | -0.91% | -15.52% | -99.4% | 17.88% | -8.21% | -55.96% | 5.55% | -80.6% | -5% | -48.45% |
FCF per Share | -0.96 | -1.12 | -1.69 | -1.21 | -0.91 | -1.23 | -1.10 | -1.81 | -1.66 | -1.63 |
FCF Conversion (FCF/Net Income) | 2.11x | 0.99x | 1.02x | 0.94x | 0.91x | 0.96x | 0.83x | 0.74x | 0.47x | 0.43x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
IVA Key Ratios
Inventiva S.A. (IVA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -17.95% | -34.55% | -53.53% | -58.69% | -44.06% | -49.62% | -80.8% | -1642.76% | - | 731.45% |
| Return on Invested Capital (ROIC) | -60.36% | -185.4% | -397.55% | -356% | -209.81% | -279.04% | -1506.6% | - | - | 232.51% |
| Gross Margin | 84.27% | 81.05% | 69.75% | 100% | 1187.37% | 100% | 140.05% | 100.13% | 100% | 92.51% |
| Net Margin | -74.59% | -264.22% | -1051.49% | -431.85% | -9037.37% | -1183.5% | -445.64% | -631.84% | -2002.74% | -1375.32% |
| Debt / Equity | 0.02x | 0.01x | 0.04x | 0.00x | 0.09x | 0.11x | 0.76x | - | - | -6.11x |
| Interest Coverage | -1724.82x | -3934.53x | -136.83x | -10104.00x | -450.27x | -377.64x | -80.78x | -19.84x | -8.01x | -15.39x |
| FCF Conversion | 2.11x | 0.99x | 1.02x | 0.94x | 0.91x | 0.96x | 0.83x | 0.74x | 0.47x | 0.43x |
| Revenue Growth | 93.77% | -30.96% | -50.97% | 118.89% | -94.68% | 1027.42% | 190.39% | 43.5% | -47.37% | 15.39% |
Related:IVA Dividend History·IVA Revenue History·IVA Price History·IVA P/E History·IVA Financial Ratios·IVA Institutional Holders
IVA Frequently Asked Questions
Inventiva S.A. (IVA) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Inventiva S.A. (IVA) reported $30.2M in revenue for fiscal year 2024. This represents a 885% increase from $3.1M in 2013.
Inventiva S.A. (IVA) saw revenue decline by 47.4% over the past year.
Inventiva S.A. (IVA) reported a net loss of $415.3M for fiscal year 2024.
Dividend & Returns
Inventiva S.A. (IVA) had negative free cash flow of $176.9M in fiscal year 2024, likely due to heavy capital investments.